E-LIB Suche - Ergebnisse für: Romero‐Gómez, M.

1

Editorial: looking for patients at risk of cirrhosis in the..:

Ampuero, J. ; Romero‐Gómez, M.
Alimentary Pharmacology & Therapeutics. 47 (2018) 5 - p. 692-694 , 2018

2

Improvement in liver histology due to lifestyle modificatio..:

Vilar‐Gomez, E. ; Calzadilla‐Bertot, L. ; Friedman, S. L....
Alimentary Pharmacology & Therapeutics. 45 (2016) 2 - p. 332-344 , 2016

Link: https://doi.org/10.1111/..

3

Simeprevir in combination with sofosbuvir in treatment‐naïv..:

Buti, M. ; Calleja, J. L. ; Lens, S....
Alimentary Pharmacology & Therapeutics. 45 (2016) 3 - p. 468-475 , 2016

Link: https://doi.org/10.1111/..

4

Review article: HCV genotype 3 – the new treatment challeng:

Ampuero, J. ; Romero‐Gómez, M. ; Reddy, K. R.
Alimentary Pharmacology & Therapeutics. 39 (2014) 7 - p. 686-698 , 2014

Link: https://doi.org/10.1111/..

5

Hepatitis C virus infection alters lipid metabolism dependi..:

Rojas, Á. ; del Campo, J. A. ; Maraver, M....
Journal of Viral Hepatitis. 21 (2013) 1 - p. 19-24 , 2013

Link: https://doi.org/10.1111/..

6

Meta‐analysis: pegylated interferon α‐2a achieves higher ea..:

Romero‐Gómez, M. ; Planas, R. ; Ampuero, J....
Alimentary Pharmacology & Therapeutics. 37 (2013) 11 - p. 1065-1073 , 2013

Link: https://doi.org/10.1111/..

7

Insulin resistance predicts sustained virological response ..:

del Campo, J. A. ; Ampuero, J. ; Rojas, L....
Alimentary Pharmacology & Therapeutics. 37 (2012) 1 - p. 74-80 , 2012

Link: https://doi.org/10.1111/..

8

Meta‐analysis: insulin resistance and sustained virological..:

Eslam, M. ; Aparcero, R. ; Kawaguchi, T....
Alimentary Pharmacology & Therapeutics. 34 (2011) 3 - p. 297-305 , 2011

Link: https://doi.org/10.1111/..

9

Treatment of chronic he1patitis C genotype 1 with peginterf..:

DIAGO, M. ; OLVEIRA, A. ; SOLÁ, R....
Alimentary Pharmacology & Therapeutics. 25 (2007) 8 - p. 899-906 , 2007

Link: https://doi.org/10.1111/..

10

Clinical trial: pharmacodynamics and pharmacokinetics of re..:

DIAGO, M. ; CRESPO, J. ; OLVEIRA, A....
Alimentary Pharmacology & Therapeutics. 26 (2007) 8 - p. 1131-1138 , 2007

Link: https://doi.org/10.1111/..

11

585 Computer-performed optical analysis of conventional hel..:

GOMEZGONZALEZ, E ; ROMEROGOMEZ, M ; VERAVALENCIA, M...
Hepatology. 38 (2003) - p. 443-443 , 2003

Link: https://doi.org/10.1016/..

12

Three‐day intravenous triple therapy is not effective for t..:

Romero‐Gómez, M. ; Martínez‐Delgado, C. ; Hergueta, P....
Alimentary Pharmacology & Therapeutics. 18 (2003) 10 - p. 1023-1029 , 2003

Link: https://doi.org/10.1046/..

13

1219 Insulin resistance impairs sustained response rate to ..:

ROMEROGOMEZ, M ; CORPAS, R ; GRANDE, L...
Hepatology. 38 (2003) - p. 747-747 , 2003

Link: https://doi.org/10.1016/..

14

311 Longer treatment duration with peginterferon alfa-2A (4..:

SANCHEZTAPIAS, J ; DIAGO, M ; ESCARTIN, P...
Hepatology. 38 (2003) - p. 306-306 , 2003

Link: https://doi.org/10.1016/..

15

1207 High-dose peginterferon alfa-2A (40KD) (PEGASYS) and r..:

DIAGO, M ; ROMEROGOMEZ, M ; DEVALME, H...
Hepatology. 38 (2003) - p. 740-741 , 2003

Link: https://doi.org/10.1016/..